Pfizer and BioNTech begin a study of an Omicron vaccine, with initial results expected in the first half of the year.
![](https://static01.nyt.com/images/2022/01/25/us/25virus-briefing-pfizer/25virus-briefing-pfizer-mediumThreeByTwo440.jpg)
By BY BENJAMIN MUELLER from NYT Health https://ift.tt/3tZVqr6
via
Pfizer and BioNTech begin a study of an Omicron vaccine, with initial results expected in the first half of the year.
Reviewed by news100
on
2:05 PM
Rating:
No comments